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Abstract
Background: The increasing use of smartphones by older adults also increases their potential for improving
different aspects of health in this population. Some studies have shown promising results in the improvement of
cognitive performance through lifestyle modification. All this may have a broad impact on the quality of life and
carrying out daily living activities. The objective of this study is to evaluate the effectiveness of combining the use
of smartphone and smartband technology for 3 months with brief counseling on life habits, as opposed to
providing counseling only, in increasing physical activity and improving adherence to the Mediterranean diet.
Secondary objectives are to assess the effect of the intervention on body composition, quality of life, independence
in daily living activities and cognitive performance.
Methods: This study is a two-arm cluster-randomized trial that will be carried out in urban health centers in Spain.
We will recruit 160 people aged between 65 and 80 without cardiovascular disease or cognitive impairment (score
in the Mini-mental State Examination ≥24). On a visit to their center, intervention group participants will be
instructed to use a smartphone application for a period of 3 months. This application integrates information on
physical activity received from a fitness bracelet and self-reported information on the patient’s daily nutritional
composition. The primary outcome will be the change in the number of steps measured by accelerometer.
Secondary variables will be adherence to the Mediterranean diet, sitting time, body composition, quality of life,
independence in daily living activities and cognitive performance. All variables will be measured at baseline and on
the assessment visit after 3 months. A telephone follow-up will be carried out at 6 months to collect self-reported
data regarding physical activity and adherence to the Mediterranean diet.
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Discussion: Preventive healthy aging programs should include health education with training in nutrition and
lifestyles, while stressing the importance of and enhancing physical activity; the inclusion of new technologies can
facilitate these goals. The EVIDENT-AGE study will incorporate a simple, accessible intervention with potential
implementation in the care of older adults.
Trial registration: ClinicalTrials.gov Identifier: NCT03574480. Date of trial Registration July 2, 2018.
Keywords: Older adult, Physical activity, Nutrition, Body composition, Quality of life
Background
The progressive aging of the population calls for the
launch of programs aimed at achieving healthy aging so
that people can maintain their autonomy for as long as
possible. Active aging is defined by the WHO as “the
process of optimizing opportunities for health, participa-
tion and security, in order to enhance the quality of life
as people age” [1], which could be achieved through in-
terventions or health promotion and prevention pro-
grams which include innovative and cost-effective
strategies, such as the use of various digital health tech-
nologies [2].
New technologies and strategies to help older adults
modify their lifestyles
Mobile health, or mHealth, is a fundamental support
tool for clinical practice and in particular for informa-
tion gathering and communication between health care
professionals and patients. Mhealth includes the use of
mobile phones, patient monitoring devices and other
wireless devices, and is used for both the prevention,
diagnosis and treatment of chronic diseases and the pro-
motion of healthy lifestyles [3–5]. One of the most re-
cent reviews on this topic indicates that interventions
using smartphones have managed to improve physical
activity and adiposity markers, obtaining greater effect-
iveness by combining these interventions with individu-
alized counseling [6]. Although the adoption of digital
technology related to health among the elderly has been
slow, this trend is being modified by the development of
easier-to-use devices [7, 8]. It is estimated that 60% of
older adults regularly use the Internet and 18% have a
smartphone, computer or tablet [8]. In addition, 30%
regularly search for health information online [7]. The
routine integration of digital technology into the health
management strategies of older people will increase as
people become more digitally experienced [9]. In an
intervention based on the use of pedometers carried out
among the adult population which included people up
to 75 years of age [10], the number of steps rose by ap-
proximately one-tenth and walking intensity was also in-
creased. However, it has not been investigated whether
the effect on behavioral changes among people over the
age of 60 could be greater if multiple lifestyle changes
were addressed at the same time.
New technologies and strategies to help older adults
reduce weight and modify body composition
Obesity affects more than 35% of people over 65 in de-
veloped countries, with figures doubling over the last 30
years [11] alongside increasing morbidity and mortality
[12–15]. In addition, weight gain in this age group
mainly involves an increase in adipose tissue, which is
responsible for the complications associated with obesity
[16, 17] and a decrease in muscle mass, leading to
greater functional disability [18–20]. Action on obesity
in the ≥65 s should take into account associated comorbid-
ity and functional limitations [16, 21, 22]. The different
strategies aimed at weight loss for older subjects have ob-
tained controversial results [16, 17]. In most of the inter-
ventions performed in this age group, weight loss is
associated with an increase in the loss of muscle and bone
mass. [16, 23]. It is thus necessary to seek a balance, minim-
izing the negative effects while pursuing the advantages of
reducing excess body weight [23]. Interventions involving
new technologies have been carried out mostly among
young people and the adult population, with very few in-
volving subjects ≥65. In general, these interventions have
yielded positive results, as reflected in several meta-analyses
[6, 24–26] and numerous clinical trials [27–32]. On the
other hand, most studies used small samples and did not
assess whether weight loss was obtained at the expense of
fat mass or lean mass.
New technologies to help older adults improve quality of
life and daily living activities
One of the goals of mHealth is to involve patients in the
design and implementation of strategies to improve
health and increase the general quality of life [33].
Health is closely linked to quality of life aspects, such as
psychological well-being, autonomy, mobility, safety and
social participation [34]. In turn, these aspects are af-
fected by personal and environmental factors [35] which
are conditioned by the state of health and which usually
worsen with age [36]. Older people are interested in
finding out about applications that could be useful in
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the realization of their daily activities [37], which sug-
gests that such tools may help them in adapting to the
environment and enable them to carry out daily living
activities. Independence is imperative for older adults in
order to avoid social exclusion [38], and in terms of con-
trol and choice, it is also of great importance when they
access health services via mobile applications. Therefore,
this type of device appears to perform an important ser-
vice by promoting mobility and autonomy among older
adults, which in turn can positively affect their quality of
life [39].
New technologies to help older adults improve cognitive
performance
Increasing longevity has led to a growing prevalence of
neurodegenerative diseases and ensuing cognitive deteri-
oration and dementia. Recent studies suggest that main-
taining a healthy lifestyle is associated with a lower risk of
cognitive impairment [40, 41]. Indeed, it appears that
maintaining certain eating patterns and healthy lifestyles,
such as physical activity, could prevent it [42]. Thus, inter-
ventions focused on increasing physical activity and adher-
ence to the Mediterranean diet, separately and in
combination, not only reduce the risk of cognitive decline,
but are also able to improve cognitive performance in
healthy older people [43, 44]. Moreover, interest in the ef-
fect that the use of mHealth and new technologies in par-
ticular can have on cognitive performance is growing.
Although more studies are needed in this area, existing re-
sults are promising. It has been proved that specific phys-
ical exercise interventions using mobile applications have
beneficial health effects for healthy older adults and even
patients with mild cognitive impairment and dementia; it
has also been shown that they have no difficulty in adapt-
ing to the use of these new technologies [45, 46].
The use of electronic devices and smartphones by the
older population has grown significantly, a fact which in-
creases the potential for their use to improve different as-
pects of health for this age group. Most studies so far have
been carried out with the young adult or middle-aged
population; thus, despite their potential, the usefulness of
new technologies has been little studied in older adults.
There are some pilot studies noting the combined effect
of these technologies alongside professional advice in life-
style improvement, but the size of these studies does not
adequately substantiate this relationship and its relevance
in clinical terms. Results of the EVIDENT II study [47],
which was carried out with adults, show that an interven-
tion combining standardized counseling on diet and PA
with the use of an app which incorporates personalized
recommendations achieves beneficial results in terms of
modifying anthropometric measurements among women.
These results include a reduction in visceral adiposity. In
addition, other studies have provided promising results in
improving cognitive performance when maintaining a
healthy lifestyle, even in people with mild cognitive im-
pairment. All this may have a far-reaching impact on the
quality of life and reduce cardiovascular risk factors.
Hypothesis and objective
The main hypothesis of the EVIDENT-Age study is that
lifestyle improvements among the over-65 population,
achieved through the combined use of smartphones and
smartbands, could have an influence in terms of improv-
ing body composition, quality of life, daily living activ-
ities and cognitive performance.
The objective of this study is to assess the effectiveness
of the combined use of smartphone and smartband tech-
nology for 3 months alongside brief counseling on life
habits, versus counseling alone, in increasing physical
activity and improving adherence to the Mediterranean
diet. As a secondary objective, we will assess the effect
of the intervention on body composition, quality of life,
daily living activities and cognitive performance.
Methods/design
Trial design
This study is a controlled and randomized parallel-group
clinical trial, to be carried out in three health centers of
the community of Castilla y León in Spain (La Alame-
dilla Health Centre, Garrido Sur Health Centre and
Miguel Armijo Health Centre). The study has been reg-
istered at ClinicalTrials.gov Identifier: NCT03574480.
Date of trial Registration July 2, 2018. The study was de-
signed in accordance with the SPIRIT guidelines [48].
Participants
Participants will be selected in the primary care surgeries
of the participating health centers by consecutive sam-
pling among those who meet the selection criteria. A
member of the research staff will then give candidates
the necessary information, after which they voluntarily
sign the informed consent. In the case of older people
who have difficulties reading and understanding consent
properly, research staff will read them the information it
contains and explain it.
The subjects will be informed of the objectives of the
project and of the risks and benefits of the research to
be carried out, including collection of samples. Confi-
dentiality of participant data will be guaranteed at all
times in accordance with the provisions of the Organic
Law on the Protection of Personal Data (15/1999 of De-
cember 13, LOPD), and under the conditions established
by Law 14/2007 of Spanish biomedical research.
Inclusion criteria
Patients of both sexes treated in the health center sur-
geries, and aged between 65 and 80. Score equal to or
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greater than 24 points in the Mini Mental State Examin-
ation (MMSE).
Exclusion criteria
People who cannot perform physical activity or follow a
Mediterranean diet; coronary or cerebrovascular athero-
sclerotic disease, grade II or higher heart failure according
to New York Heart Association (NYHA) criteria, moder-
ate or severe chronic obstructive pulmonary disease, mus-
culoskeletal disease limiting ambulation, advanced kidney
or liver disease, severe mental illness, and cancer under
treatment diagnosed in the previous 5 years or terminal.
Sample size calculation
The sample size was estimated for the main variable of
the study (Physical activity - steps/day). Assuming a stand-
ard deviation of 3847 steps/day [49], a power of 0.8 and
an alpha risk of 0.05 in a bilateral test, 80 participants are
necessary in each group to detect an increase of 1850
steps/day in the experimental group compared to the con-
trol group. This calculation was based on the estimate by
Alonso-Dominguez et al. [50]. We assumed a dropout rate
of 15% throughout the duration of the study (3months).
Randomization
Participants will be randomly assigned to the interven-
tion (IG) or control group (CG) – Fig. 1. The allocation
sequence will be generated by an independent researcher
using Epidat 4.2 [51] and will remain secret until the
participants are assigned to each group.
Intervention
Common to both groups: before randomization, all partic-
ipants (control and intervention), will receive nutritional
Fig. 1 EVIDENT-Age study flow chart
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counseling aimed at good compliance with the Mediterra-
nean diet. Counseling will consist of a 10-min individual
appointment in which the ideas behind the Mediterranean
diet will be outlined, as well as the health benefits and evi-
dence generated by this pattern of nutrition. Both groups
will also receive brief counseling on physical activity aimed
at complying with the current recommendations for both
the general and the elderly population, and will be advised
to perform at least 30min of moderate activity for five
days a week, or 20min of vigorous activity three days a
week. Participants will be provided with an informative
leaflet at the end of the session.
Specific intervention in the experimental group: Par-
ticipants in the intervention group will be issued with a
smartphone (Samsung Galaxy J3) and a smartband
(Xiaomi Miband S2) for the duration of intervention (3
months). During an approximately 15-min visit, each
participant will be trained to use the device and the app
developed for the EVIDENT 3 study [52] (Intellectual
Property Registry No. 00/2017/2438), which is
pre-installed on the smartphone. In the first part of this
visit, the app will be configured with a series of data
(age, sex, weight and height) which will allow the daily
energy needs of each participant to be calculated. The
app allows daily monitoring of food and physical activity
by integrating the information collected by the smart-
band regarding physical activity (steps, calories and heart
rate) and information related to food after the subject
has logged food or dishes eaten each day, selected from
the app menu –Fig. 2. At the end of the day, the applica-
tion makes recommendations and a personalized plan to
improve eating habits and physical activity over the fol-
lowing days. At the 3-month visit, the devices will be
taken back.
Data collection / outcomes
Each participant will undergo a baseline assessment and
a follow-up evaluation at 3 months. Some variables
(self-reported physical activity and adherence to the
Mediterranean diet) will also be collected in a follow-up
phone call at 6 months. The information generated by
the app during the intervention period (physical activity
and food) will also be analyzed. An overview of data col-
lection is presented in Table 1.
Primary outcome
Physical activity
The main physical activity variable will be the change in
the amount and intensity of physical activity expressed
in steps/day, measured by accelerometer. This device
also calculates the total time spent daily in light, moder-
ate and intense physical activity and the kilocalories
used. Validated GT3X accelerometers will be used [53].
Participants will wear the accelerometer strapped to the
right side of their waist with an elastic belt for seven
consecutive days. Data will be recorded minute by mi-
nute. If the accelerometer records 10 consecutive zeros
over the course of 10 min, the measurement will be con-
sidered null. The intensity of physical activity (low, mod-
erate or high) will be determined according to the cut
points proposed by Freedson [54]. Physical activity will
also be measured by self-report using the International
Physical Activity Questionnaire (IPAQ). The short ver-
sion will be used, which is validated in Spanish and as-
sesses physical activity over the last 7 days [55]. This
questionnaire classifies adult populations by their level
of activity (low, moderate and high) and differentiates
three types of activity: walking, moderate activity and
vigorous activity. The physical activity dose will be
Fig. 2 Screenshots of the EVIDENT smartphone application
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estimated in METs/minute/week. An active person is
considered to be someone who performs at least 30 min
of moderate activity, five days a week, or at least 20 min




The number of daily hours spent sitting will be collected
using the questionnaire developed by Marshall et al.
[56], which evaluates the hours that the individual re-
mains seated while working, traveling and during leisure
activities involving screens (television, computer, tablets/
smartphone). The questionnaire differentiates between
work and non-work days.
Dietary pattern
The change in adherence to the Mediterranean diet
(MD) will be measured by the total scores (baseline and
final) on the Mediterranean diet adherence question-
naire. This questionnaire, validated in Spain, has been
used in the PREDIMED study [57] and asks 14 questions
regarding MD compliance. Each question is scored with
zero or one point. One point is given for using olive oil
as the main fat for cooking, preferring white meat to red
meat, daily consumption of four or more tablespoons
(one tablespoon = 13.5 g) of olive oil (including oil used
for frying, dressing salads, etc.), two or more servings of
vegetables, three or more pieces of fruit, less than one
serving of red meat or sausage, less than one serving of
animal fat, less than one cup (one cup = 100ml) of car-
bonated and/or sugary drinks; and also for weekly intake
of seven or more glasses of wine, three or more servings
of legumes, three or more servings of fish, two items or
fewer of shop-bought pastries, three or more servings of
nuts, two or more helpings of sofrito, (traditional sauce
made with tomato, garlic, onion or leeks, sautéed with
olive oil). The final score ranges from zero to fourteen
points, with nine or more points representing good ad-
herence to the Mediterranean diet.
Body composition
This will be measured by InBody 230 [58], which moni-
tors body weight, muscle-skeletal mass, fat mass, total
body water, fat-free mass, percentage of body fat,
waist-hip ratio, basal metabolism, muscle-fat control, in
addition to performing a segmental analysis of lean and
fat mass. Height will be measured using a portable sys-
tem (Seca 222), with the average of two measurements
being recorded.
Cognitive performance
General cognitive capacity will be assessed by applying the
Spanish validation of the Mini-Mental State Examination
(MMSE) [59]. This test allows the performance of differ-
ent cognitive functions to be tracked: temporo-spatial
orientation, attention, learning and memory, executive
functions, language and visuoconstructive skills. The score
can range from 0 to 30 points, with greater than 24 points
considered to represent normal cognitive performance. In
addition, the clock test will be applied [60] to assess visuo-
constructive skills, executive functions and language. Fi-
nally, verbal fluency ability will be measured by a
categorical fluency test in which animals are listed for one
minute [61].
Activities of daily living
The level of functionality will be assessed with the Func-
tional Activity Questionnaire (FAQ) that was designed
by Pfeffer and is based on a previous study by the same
author [62, 63]. It is a screening scale for mild cases of
dementia, with questions which assess the ability to
carry out complex social activities, the so-called instru-
mental activities of daily living. It asks about the follow-
ing 11 items: handling money, making purchases,
preparing tea or coffee and switching off the appliance,
preparing food, keeping up with community events,
Table 1 Timeline of measures
Measure Baseline 3 months 6 months
Accelerometer X X
International physical activity questionnaire (IPAQ) X X X
Marshall questionnaire- sitting time X X X
Mediterranean diet screener (MEDAS) X X X
Body composition- impedanciometer X X
Mini-Mental State Examination, the clock drawing test and categorial fluency X X
Pfeffer questionnaire X X
WHOQOL-AGE X X
EuroQoL 5-D (EQ-5D) X X
IPAQ International physical activity questionnaire, MEDAS Mediterranean diet adherence questionnaire, WHOQOL-AGE World health organization quality of life
age questionnaire
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understanding and discussing radio and television news,
reading magazines and books, remembering appoint-
ments and important dates, medication management,
traveling alone outside the neighborhood, greeting
friends and going outside alone safely. Each item scores
between 0 (normal) and 3 (totally dependent).
Quality of life
This will be assessed by a modified version of the World
Health Organization quality of life instrument called
WHOQOL-AGE that has been specially adapted for the
elderly population. This short version contains 13 of the
100 questions in the original version and has been vali-
dated in populations older than 50 years [64]. The re-
sults can range from 0 (lower quality of life) to 100
(higher quality of life). Similarly, health-related quality of
life will also be evaluated with the EuroQol 5D question-
naire (EQ-5D). We will use an adapted version of this
questionnaire which has been validated for the Spanish
population [65]. This questionnaire comprises three ele-
ments: the individual’s self-rated state of health assess-
ment in levels of severity by dimension (mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression), assessment of his or her state of health on a
visual analogue scale, and finally an index of social
values obtained for each health state generated by the
instrument.
Other variables
Motivation for change, as described by Prochaska and
Diclemente, will be assessed at baseline, classified into
the different stages of pre-contemplation, contemplation,
determination, action, maintenance and relapse. With
intervention group participants, app adherence will be
measured by the number of logs and days on the device.
Data collection procedure, data management and
monitoring
Data collection at baseline and follow-up visits at 3 and 6
months will be carried out by a specifically trained nurse.
The brief counseling session after baseline assessment will
be carried out by another nurse, different from the one re-
sponsible for data collection. Finally, a third member of
the research team, who was not involved in either data
collection or brief counseling, will be in charge of carrying
out the intervention visit. Each participant will have a
unique identification code within the study. All measure-
ments will be compiled in a data collection notebook and
kept in a secure place which will remain closed inside the
health center. A database will be created in SPSS to which
only research team members and people involved in the
statistical analyses will have access. The principal investi-
gator or a person designated for the purpose will perform
weekly study monitoring covering patient inclusion,
database cleaning and debugging, and adapting proce-
dures to the protocol.
Blinding
Given the nature of the intervention itself, participants
cannot be blinded. However, strategies will be in place to
attain the highest level of blinding possible. The re-
searcher making the visit to the intervention group to ex-
plain the app will be different from the nurse responsible
for taking the measurements and the person in charge of
carrying out brief counseling after the baseline evaluation
visit. In addition, the researcher responsible for the statis-
tical analysis will not know the group to which the partici-
pants belong. To prevent contamination between groups,
no additional counseling or reinforcement will be made
during the 3-month evaluation visit. In addition, the app




Results will be expressed by means and standard devia-
tions for quantitative variables, or by frequency distribu-
tions and percentages in the case of qualitative ones.
The normality of variables will be tested by means of the
Kolmogorov-Smirnov test. When a normal distribution
cannot be assumed, we will use the corresponding non-
parametric tests. The chi-square test or Fisher’s exact
test will be applied to analyze the association between
independent qualitative variables. Using the Student’s
t-test or the Mann-Whitney U test, the means between
the two groups will be compared. The relationship be-
tween quantitative variables will be analyzed with the
Pearson or Spearman correlation coefficients.
Analysis of the results for the main variable and the
secondary variables will be carried out by
intention-to-treat. In addition, app adherence will be the
subject of a secondary analysis, as described in the re-
sults of the EVIDENT II study [66] (< 60 days and > 60
days), and other relevant subgroups will also be analyzed
in terms of their physical activity or previous adherence
to the Mediterranean diet.
Analysis of the effect of the intervention on primary
(steps/day) and secondary outcomes
To analyze the changes at 3 and 6months’ post-baseline in
the primary (physical activity - steps/day) and the second-
ary outcome within the same group, the Student’s t-test or
the Wilcoxon test will be used for paired data. The McNe-
mar test will be used for dichotomous variables.
The intervention effect will be analyzed by comparing
the changes between IG and CG in blood pressure and
secondary variables by using ANCOVA and adjusting for
possible confounders. The intervention effect over the
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period studied will be measured by a repeated measures
analysis.
Analysis by subgroups
The intervention effect could be affected by age, sex, edu-
cational level and adherence to the application during the
study, as well as motivation and lifestyles at the baseline
assessment. The same analyses described above will be
performed for each of the aforementioned subgroups.
Secondary analyses
Multiple multivariate regression analysis will be per-
formed to identify the variables with the greatest influ-
ence on physical activity changes and the secondary
variables analyzed.
All analyses will be carried out with SPSS version 23.0
(IBM Corporation, Armonk, NY, USA) and an alpha risk
of 0.05 will be assumed as the limit for statistical
significance.
Discussion
Physical inactivity in people over 65 across Europe [67]
makes it necessary to develop strategies and interven-
tions aimed at healthy aging by maintaining older adult
health, autonomy and independence for as long as pos-
sible. The promotion of a general framework to guide
the design of healthy aging programs from a preventive
approach which considers the essential aspects involved
in aging would therefore be welcome. Such programs
should include health education with training in nutri-
tion and lifestyles, while focusing on and enhancing
physical activity [68]. The promotion research on the
aging process and rigorous assessment of all aspects of
healthy living are necessary to achieve these objectives.
It has been proven that increased physical activity and
healthy eating has health implications for the over-65 s
[69]. This fact, alongside the unceasing incorporation of
information technologies into the daily lives of older
adults and their use as tools to adopt and maintain health-
ier lifestyles, makes it necessary to design simple and ef-
fective applications aimed at this population group. The
novelty of the EVIDENT-Age study lies in the combin-
ation of brief lifestyle counseling with the use of a smart-
phone application. The effect of this application has been
studied on the health of the general population, the over-
weight or obese population and the population of diabetes
mellitus type 2 sufferers [50, 52, 70]. We have modified
the application to take into account the characteristics of
the study population; thus, for example, font size has been
increased and the way the content is presented has been
modified. In addition, the application has features which
have been described as essential for the elderly, such as
continuous feedback for the app user, target setting and
rewards, as well as the inclusion of social factors.
Nevertheless, it is not clear which of these components
may be more effective in achieving the objectives [71].
The effects of this intervention can be quickly transferred
to clinical practice or included in health education pro-
grams for older adults. The results of this work will be
communicated to participants and sponsors, as well as to
health professionals and the general public. The study will
result in several different publications in peer reviewed
journals.
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